Perspectives on Risk and Regulation: The FDA at 100
Edited by Arthur Daemmrich and Joanna Radin
2007, Chemical Heritage Foundation
166 pp.
Paper, 6 x 9, ISBN 978-0-941901-42-0
$13.00
Products regulated by the U.S. Food and Drug Administration (FDA) are ubiquitous in modern life, and many are vital to nutrition and health. Yet the FDA is frequently mired in controversies concerning innovation and product safety. Based on talks presented at a conference marking the FDA’s centennial, Perspectives on Risk and Regulation offers a unique set of viewpoints and predictions by FDA and industry leaders for the future of food, drug, medical device, and nutritional supplement regulation.
Chapters alternate between regulators and industry representatives, providing incisive suggestions and recommendations for fostering relationships while maintaining a commitment to consumer health. By placing these perspectives within the history of the FDA, the book presents readers with new tools for evaluating policy recommendations and assessing pressing regulatory issues.